Almost one in five patients with advanced melanoma survived for five years after receiving lifileucel, with tumours shrinking ...

The Royal Horticultural Society has named a coral-pink rose "Catherine’s Rose" in honor of the Princess of Wales to raise ...

Approximately 70% of breast cancers are HR-positive/HER2 negative. While activating ESR1 mutations are rare at the time of ...

A “breakthrough” new three-drug combination offers hope for women battling an aggressive form of breast cancer, potentially ...

A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...

Together with its principal academic partner, The Institute of Cancer Research (ICR), The Royal Marsden is designated as the ...

The NIHR-funded collaboration aims to improve cancer detection and diagnosis through advanced artificial intelligence models ...

Almost one in five patients with advanced melanoma survived for five years after receiving lifileucel, a trial has found.

Almost 2,000 patients were waiting for routine treatment at the Royal Marsden Trust in March, new figures show.It comes as a health and social care think tank warned efforts to reduce patients' ...

The Royal Marsden NHS Foundation Trust in the UK has cured its first patient with an workflow enabled by RayStation's new adaptive replanning module. This marks an advancement in the treatment ...

The Royal Marsden NHS Foundation Trust using AI to push boundaries of cancer research with NTT DATA and CARPL.ai ...

Funded by a three-year grant from the UK’s National Institute for Health and Care Research (NIHR), the service will be used for research at The Royal Marsden and the Institute of Cancer Research ...